Valuation: Ibnsina Pharma

Market Cap 1.06TCr 20Cr 17Cr 16Cr 15Cr 28Cr 1.84TCr 28Cr 192.44Cr 77Cr 982.85Cr 74Cr 72Cr 3.1TCr P/E 2026 *
9.27x
P/E 2027 * 7.09x
Enterprise Value 1.92TCr 36Cr 32Cr 29Cr 27Cr 50Cr 3.34TCr 52Cr 349.8Cr 139.42Cr 1.79TCr 133.63Cr 130.77Cr 5.63TCr EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.17x
Free-Float
58.26%
Yield 2026 *
2.77%
Yield 2027 * 3.92%
1 day+1.06%
1 week+14.55%
Current month+4.80%
1 month-10.51%
3 months-24.02%
6 months-7.35%
Current year-10.67%
1 week 9.7
Extreme 9.7
10.7
1 month 9.02
Extreme 9.02
11.72
Current year 9.02
Extreme 9.02
16.93
1 year 9.02
Extreme 9.02
16.93
3 years 2.14
Extreme 2.14
16.93
5 years 1.1
Extreme 1.101
16.93
10 years 1.1
Extreme 1.101
16.93
Manager TitleAgeSince
Chief Executive Officer - 18/12/2000
Chief Executive Officer - 18/12/2000
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 18/12/2000
Director/Board Member - 18/12/2000
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.06%+14.55%-6.10%+338.08% 20Cr
-0.37%+6.73%-30.28%+13.63% 1.75TCr
+0.34%+7.46%-8.71%+15.16% 715.35Cr
-2.04%+4.30%-7.43%+7.07% 696.53Cr
+0.33%+3.38%-47.33%-35.28% 627.69Cr
-6.46%-4.95%+6.93%-15.13% 459.88Cr
-0.07%-2.63%-29.69%-41.48% 469.49Cr
-4.42%-0.05%+12.30%-16.57% 350.44Cr
-1.37%+2.33%-16.55%-18.80% 321.19Cr
+0.81%+3.05%-15.94%-29.27% 318.82Cr
Average -1.22%+3.77%-14.28%+21.74% 573Cr
Weighted average by Cap. -1.11%+4.93%-19.39%-4.11%

Financials

2026 *2027 *
Net sales 9.44TCr 175.18Cr 156.36Cr 143.88Cr 130.59Cr 247.48Cr 16TCr 253.62Cr 1.72TCr 686.03Cr 8.79TCr 657.52Cr 643.45Cr 28TCr 10TCr 190.75Cr 170.26Cr 156.67Cr 142.2Cr 269.48Cr 18TCr 276.17Cr 1.87TCr 747.02Cr 9.57TCr 715.97Cr 700.65Cr 30TCr
Net income 118.3Cr 2.2Cr 1.96Cr 1.8Cr 1.64Cr 3.1Cr 205.78Cr 3.18Cr 22Cr 8.6Cr 110.17Cr 8.24Cr 8.06Cr 346.99Cr 158.27Cr 2.94Cr 2.62Cr 2.41Cr 2.19Cr 4.15Cr 275.31Cr 4.25Cr 29Cr 12Cr 147.39Cr 11Cr 11Cr 464.22Cr
Net Debt 863Cr 16Cr 14Cr 13Cr 12Cr 23Cr 1.5TCr 23Cr 157.36Cr 63Cr 803.7Cr 60Cr 59Cr 2.53TCr 681.4Cr 13Cr 11Cr 10Cr 9.43Cr 18Cr 1.19TCr 18Cr 124.25Cr 50Cr 634.58Cr 47Cr 46Cr 2TCr
Projected Income Statement - Annual - Ibnsina Pharma
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
09/26/09 EGP 10.47 +1.06% 90,64,909
08/26/08 EGP 10.36 +0.88% 39,94,224
05/26/05 EGP 10.27 +1.68% 1,01,71,360
04/26/04 EGP 10.10 +6.88% 1,90,71,086
03/26/03 EGP 9.450 +3.39% 48,99,189
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Ibnsina Pharma
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.47EGP
Average target price
16.51EGP
Spread / Average Target
+57.66%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ibnsina Pharma
  1. Stock Market
  2. Stocks
  3. ISPH Stock